FDA has announced it has approved the first glaucoma stent for use with cataract surgery, according to a news release. The iStent Trabecular Micro-Bypass Stent System, model GTS100R/L, manufactured by ...
This prospective, nonrandomized, consecutive cohort study aimed to assess 36-month outcomes after cataract surgery and implantation of two second-generation trabecular microbypass stents (iStent ...
Betty Fecteau, left, 85, of West Seneca, had a tiny stent surgically placed into her right eye in May by Dr. Paul C. Holmwood, right, an ophthalmologist with Eye Care & Vision Associates, which has ...
Ophthalmologist Dr. Arnold Prywes has fulfilled a mission years in the making — helping a patient with a challenging case of glaucoma by implanting a sight-saving device that he invented in 1991.
ZURICH (Reuters) - Novartis' eye care unit Alcon is withdrawing a surgical stent for glaucoma patients after clinical data showed it may damage the eye, but the Swiss drugmaker said the move would not ...
Glaukos secured a new FDA clearance for its miniaturized stent system designed for glaucoma to help drain the inner eye of built-up fluids and normalize intraocular pressure. The company had received ...
NEW YORK (CBSNewYork) --A tiny new device could help prevent a leading cause of blindness. The glaucoma implant is the size of a human hair, and was just approved by the Food and Drug Administration.
Please provide your email address to receive an email when new articles are posted on . NEW YORK — In a presentation at OSN New York, Manjool Shah, MD, discusses how surgeons can identify patients ...
Please provide your email address to receive an email when new articles are posted on . The Xen45 gel stent is a viable option after failed trabeculectomy and has the same good results as primary ...
Glaucoma affects millions of Americans. Common treatments, although highly effective, remain invasive and prone to complications. New technology could help preserve a patient's vision while reducing ...
Microinvasive glaucoma surgery (MIGS) has revolutionized the options available to patients with mild to moderate glaucoma. Most MIGS procedures are performed in conjunction with cataract extraction ...
ZURICH, Aug 29 (Reuters) - Novartis eye care unit Alcon is voluntarily withdrawing its CyPass Micro-Stent after follow-up clinical data showed patients using the product experienced statistically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results